Short-acting agents, such as exenatide and lixisenatide, exert pronounced meal-time fullness primarily through delayed gastric emptying, while long-acting formulations including liraglutide, dulaglutide, and semaglutide sustain a more persistent satiety tone via direct activation of brain receptors
These may include mild nausea, fatigue, lightheadedness, and flu-like symptoms
In summary, PLB significantly improved the survival, mitochondrial function and antioxidant capacity of KGN cells, as well as suppressed cell damage and ferroptosis by inhibiting YTHDF1 expression
1:09:19: People who work longer versus retire sooner have better cognitive outcomes
Eligibility is determined through clinical screening, and not all applicants will qualify
Evaluation of stool short chain fatty acids profiles in the first year of life with childhood Atopy-Related outcomes